Last reviewed · How we verify

NCT05791071

Virtual Reality Intervention for Skill Acquisition Support in Autism Spectrum Disorder (ASD)

Completed Phase 2 Last updated 26 February 2025
What this trial tests

Phase 2 trial testing Floreo VR Building Social Connections in Autism Spectrum Disorder in 30 participants. Completed in 29 June 2023.

Timeline
15 February 2023
Primary endpoint
29 June 2023
29 June 2023

Quick facts

Lead sponsorFloreo, Inc.
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment30
Start date15 February 2023
Primary completion29 June 2023
Estimated completion29 June 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Floreo, Inc.

Who can join

Adults 4 to 10, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Randomized Controlled Phase II study to assess the efficacy of Floreo VR (Virtual reality) Building Social Connections as treatment for social skills in children with Autism Spectrum Disorder (ASD)

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

Other Floreo, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05791071.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing